Capricor Therapeutics is advancing deramiocel (CAP-1002) for DMD cardiomyopathy. Click here to find out why CAPR stock is a ...
Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of ...
Emily Blunt Calls AI Actress Tilly Norwood ‘Really Scary' and Warns Hollywood Agencies: ‘Don't Do That' The 'stupidity' of ...
Data from ongoing DELIVER trial demonstrated sustained functional improvement through 18 months; results from Registrational Expansion Cohort ...
FDA and Capricor aligned on endpoints for HOPE-3 pivotal trialHOPE-3 pivotal trial completed; topline data expected mid-Q4 ...
A boy in Maryville is facing a challenge that most kids will never experience. It's a rare genetic disorder that causes ...
In recent years, the U.S. Food and Drug Administration (FDA) has approved a wave of new therapies, including gene therapies, ...
Ten-year-old Sebastian Veiman is racing against time to receive €2.5 million gene therapy that could halt — or even reverse — ...
The seventh annual Calves to Cure DMD charity cattle auction raised funds to help fund research for Duchenne muscular ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...
Italfarmaco has entered into an agreement with Multicare for the regulatory approval and distribution of givinostat as a treatment for Duchenne muscular dystrophy in Brazil.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback